Altoida Overview
- Year Founded
-
2013
- Status
-
Private
- Employees
-
50
- Latest Deal Type
-
2ndary - Private
- Investors
-
20
Altoida General Information
Description
Developer of brain health assessment and neurocognitive test platform designed to detect Alzheimer's and dementia before its onset using augmented reality. The company's application tests the functional and cognitive aptitude of a patient, via a machine-learning algorithm, and offers a methodology based on longitudinal clinical studies, enabling doctors to detect Alzheimer's easily and help their patients to recover early.
Contact Information
Website
www.altoida.comCorporate Office
- 80 M Street Southeast
- Suite 100
- Washington, DC 20003
- United States
Corporate Office
- 80 M Street Southeast
- Suite 100
- Washington, DC 20003
- United States
Altoida Timeline
Altoida Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 11. Secondary Transaction - Private | Completed | Generating Revenue | ||||
| 10. Later Stage VC (Series B) | 01-Dec-2021 | Cancelled | Generating Revenue | |||
| 9. Later Stage VC (Series A) | 30-Mar-2022 | Completed | Generating Revenue | |||
| 8. Accelerator/Incubator | 09-Sep-2021 | Completed | Generating Revenue | |||
| 7. Later Stage VC (Series A) | 17-May-2019 | Completed | Generating Revenue | |||
| 6. Accelerator/Incubator | 01-Jan-2019 | Completed | Generating Revenue | |||
| 5. Seed Round | 21-Dec-2016 | Completed | Generating Revenue | |||
| 4. Grant | Completed | Generating Revenue | ||||
| 3. Seed Round | 01-Mar-2014 | $33.5K | $33.5K | Completed | Generating Revenue | |
| 2. Accelerator/Incubator | 01-Jan-2013 | Completed | Startup |
Altoida Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate ($) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A-2 | ||||||||
| Series A-1 | ||||||||
| Series A | 6,098,066 | $0.000100 | $0.09 | $2.36 | $2.36 | 1x | $2.36 | 24.02% |
| Seed | 1,911,761 | $0.000100 | $0.04 | $1.07 | $1.07 | 1x | $1.07 | 7.53% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
Altoida Comparisons
Industry
Financing
Details
Altoida Competitors (32)
One of Altoida’s 32 competitors is CNS Vital Signs, a Corporation company based in Morrisville, NC.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| CNS Vital Signs | Corporation | Morrisville, NC | ||||
| BrainCheck | Venture Capital-Backed | Austin, TX | ||||
| Savonix | Formerly VC-backed | San Francisco, CA | ||||
| Neurologix Technologies | Corporation | Cleveland, OH | ||||
| Aural Analytics | Formerly VC-backed | Scottsdale, AZ |
Altoida Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Altoida Patents
Altoida Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20230274835-A1 | System and method for identifying prodromal parkinson's disease | Pending | 14-Feb-2022 | ||
| EP-4430634-A1 | System and method of analysing data for the determination of the condition of a person | Pending | 09-Nov-2021 | ||
| JP-2024542414-A | Systems and methods for analyzing data to assess a human medical condition - patents.com | Pending | 09-Nov-2021 | ||
| US-20250006369-A1 | System and method of analysing data for the determination of the condition of a person | Pending | 09-Nov-2021 | ||
| CA-3222403-A1 | Method and system for obtaining measurement of cognitive performance | Pending | 17-Jun-2021 | A61B5/4088 |
Altoida Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Altoida Investors (20)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| b2venture | Venture Capital | Minority | ||
| Eisai Innovation | Corporate Venture Capital | Minority | ||
| Hikma Ventures | Corporate Venture Capital | Minority | ||
| HonorHealth | Corporation | Minority | ||
| Whitecap Venture Partners | Corporate Venture Capital | Minority |
Altoida FAQs
-
When was Altoida founded?
Altoida was founded in 2013.
-
Where is Altoida headquartered?
Altoida is headquartered in Washington, DC.
-
What is the size of Altoida?
Altoida has 50 total employees.
-
What industry is Altoida in?
Altoida’s primary industry is Other Healthcare Technology Systems.
-
Is Altoida a private or public company?
Altoida is a Private company.
-
What is Altoida’s current revenue?
The current revenue for Altoida is .
-
How much funding has Altoida raised over time?
Altoida has raised $21.3M.
-
Who are Altoida’s investors?
b2venture, Eisai Innovation, Hikma Ventures, HonorHealth, and Whitecap Venture Partners are 5 of 20 investors who have invested in Altoida.
-
Who are Altoida’s competitors?
CNS Vital Signs, BrainCheck, Savonix, Neurologix Technologies, and Aural Analytics are some of the 32 competitors of Altoida.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
